Legal Opinion
To: Zhejiang Tailin Biotechnology Co., Ltd.
Grandall Law Firm (Hangzhou) (hereinafter referred to as "this Firm") accepts the commission from Zhejiang Tailin Biotechnology Co., Ltd. (hereinafter referred to as "the Company") to provide legal opinions regarding the first extraordinary shareholders' meeting of the Company in 2026 (hereinafter referred to as "the Meeting"), and based on the "Company Law," "Securities Law," and the relevant regulations issued by the China Securities Regulatory Commission (hereinafter referred to as "CSRC"), the following legal opinions are provided: